publication venue for
- Answers in search of questions: what does the comparison of COVID19 data among regions in Northern Italy tell us?. 17:224-226. 2022
- (Re)defining legitimacy in Canadian drug assessment policy? Comparing ideas over time. 16:424-439. 2021
- Demand-based models and market failure in health care: projecting shortages and surpluses in doctors and nurses. 14:291-294. 2019
- Pharmaceutical policy reform in Canada: lessons from history. 13:299-322. 2018
- The determinants of efficiency in the Canadian health care system. 11:39-65. 2016
- Reflecting on ‘Equity in health care: the Irish perspective’. 10:443-447. 2015
- On the margins of health economics: a response to ‘resolving NICE’S nasty dilemma’. 10:183-193. 2015
- The impact of health insurance on health services utilization and health outcomes in Vietnam. 9:359-382. 2014
- User charges for health care services: some further thoughts. 8:537-541. 2013
- Empirically evaluating the impact of adjudicative tribunals in the health sector: context, challenges and opportunities. 7:147-174. 2012
- A discrete choice experiment investigating preferences for funding drugs used to treat orphan diseases: an exploratory study. 6:405-433. 2011
- Access as a policy-relevant concept in low- and middle-income countries. 4:179-193. 2009
- Access to psycho-social resources and health: exploratory findings from a survey of the French population. 3:365-391. 2008
- Mental health service delivery in Ontario, Canada: how do policy legacies shape prospects for reform?. 2:363-389. 2007
- Mental health service delivery in Ontario, Canada: how do policy legacies shape prospects for reform?. 2:363-389. 2007
- Being naughty about NICE? Questioning the methods used to maximize health gains from NHS resources. 2:217-221. 2007
- Economists’ dream or nightmare? Maximizing health gains from available resources using the NICE guidelines. 2:193-202. 2007